Table 2.
Tumor characteristics in the cTACE cohort.
| Tumor | |
| Single | 134 (30.2) |
| Multiple | 310 (69.8) |
| Lobe | |
| Right | 141 (31.8) |
| Left | 44 (9.9) |
| Bilobar | 152 (34.2) |
| Central | 107 (24.1) |
| Venous thrombus | |
| Yes | 58 (13.1) |
| AJCC 7th Stage | |
| I/II | 322 (72.5) |
| III | 122 (27.5) |
| TACE approach | |
| Superselective | 356 (80.2) |
| Lobar | 88 (19.8) |
| Treatment | |
| Primary | 355 (80.0) |
| Recurrence | 89 (20.0) |
Values indicate numbers (percentages) of patients with each characteristic.
cTACE, conventional transarterial chemoembolization; TACE, transarterial chemoembolization; AJCC, American Joint Committee on Cancer.